Jeongjun Kim

The Angiogenesis Inhibitor ALS-L1023 from Lemon-Balm Leaves Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Regulating the Visceral Adipose-Tissue Function

Jeongjun Kim, Haerim Lee, Jonghoon Lim et al. · International Journal of Molecular Sciences · 2017 · 41 citations · Full text

Life Sciences, Biochemistry, Inflammation +16

Safety, Tolerability, and Pharmacokinetics of Telacebec (Q203), a New Antituberculosis Agent, in Healthy Subjects

Jeongjun Kim, Jin‐Ho Choi, Hwankyu Kang et al. · Antimicrobial Agents and Chemotherapy · 2021 · 39 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Reduction of Adipose Tissue Mass by the Angiogenesis Inhibitor ALS-L1023 from Melissa officinalis

Byung Young Park, Hyunghee Lee, Sangee Woo et al. · PLoS ONE · 2015 · 37 citations · Full text

Life Sciences, Biochemistry, Metabolic Regulation +15

Telacebec for Ultrashort Treatment of Buruli Ulcer in a Mouse Model

Deepak V. Almeida, Paul J. Converse, Till F. Omansen et al. · Antimicrobial Agents and Chemotherapy · 2020 · 34 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

The lemon balm extract ALS-L1023 inhibits obesity and nonalcoholic fatty liver disease in female ovariectomized mice

Jeongjun Kim, Hyunghee Lee, Jonghoon Lim et al. · Food and Chemical Toxicology · 2017 · 31 citations

Life Sciences, Biochemistry, Endocrinology +12